Considering the mesenchymal GBM subtype is featured with more infiltrating tumor-associated macrophages (TAMs) and immunosuppression (33), we speculated that CD44 may play an important role in glioma immune environment. This evidence concerns the gene CD44 and central nervous system cancer.